Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://www.krupainvestments.com/content/uploads/2020/01/kgi_kgi-announces-position-in-nmc-health_15-1-2020-1.pdf
Krupa Global Investments announces position in NMC Health; Sees NMC shares deeply undervalued
15th January, 2020, Prague, Czech Republic
Krupa Global Investments (KGI) bought 1,000,000 shares of NMC Health (NMC), UAE-based hospital and health care provider and FTSE 100 company which has been under fire from short seller hedge fund Muddy Waters (MW).
KGI has been monitoring situation around NMC for quite some time since Muddy Waters published report which took down more than 70% of NMC value. KGI suggests that ‘facts’ in MW report might be relevant but not significant enough that NMC should go bankrupt or go out of the business based on this information. KGI has analysed report from Muddy Waters and NMC valuation closely and we believe that shares of NMC are deeply undervalued at these levels even in situation that everything mentioned in MW report is true which is highly unlikely. In our opinion, shares would be fairly valued around 2000 GBP per share relative to peers. NMC is dominant health care provider in UAE and their expansion plans into other Middle East countries will enhance their growth and bring valuation much higher when MW report crisis fades away.
Another reason for undervalued NMC shares is sale of significant stake by biggest shareholders. KGI claims event that happened in recent days when two biggest shareholders sold significant stake in NMC for price of 1200 GBP per share was intentional and not due to the reasons they mentioned. Shares of NMC were significantly higher just couple of weeks before the announced sale with trading volume exceeding average. These shareholders could sell their stakes at higher price in market, in our opinion, if the main motivation would be to get cash a pay down their debt in other ventures and businesses. KGI thinks that this kind of action from biggest shareholders might be intentional to secure lower price for certain time and open door for other potential investors. Process of sale takes several weeks and months to execute via advisors and banks, it’s not one day process which leave us suspicious as well.
We have seen this happening in August 2019 when MW started their campaign. Shares of NMC plummeted on the news, but few days later several Chinese investors including Fosun Group were interested in buying huge stake in company and shares rose back to the levels before MW report. KGI suggests that similar situation can occur now.
NMC Health is well positioned to gain market share in Gulf region mainly in Saudi Arabia and increase their penetration in UAE and UK. In our opinion, further growth will be led by huge capacities in their hospitals and profitable distribution channels, when this crisis fades away. KGI would like to hear from NMC representatives their arguments on recent events that happened in last few weeks and KGI will initiate meeting in UK or Abu Dhabi. KGI will listen closely what CEO of NMC Health has to say in conference call organized by Barclays on 27th of January 2020.
”NMC should prove their further growth prospects and margin expansion and I would like to hear personally from management their arguments regarding Muddy Waters report and fire sale of two key shareholders of NMC, significantly below market price. If we get clear answers and understand whole situation better which took place in recent weeks, we will be very supportive shareholder,” says Pavol Krupa, chairman of Krupa Global Investments.
are you just copying my posts?? lol
Lol you’re beating me to it today!
Q